DepoMed, Inc. (DEPO) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Nasdaq, S&P 500 slip from record highs as yields and oil rebound
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Total costs and expenses: 109.27M
Today's EPS Names:
AEHR, VFS, CMTL, More
Financial Fact:
Total costs and expenses: 109.27M
Today's EPS Names:
AEHR, VFS, CMTL, More
Join SI Premium – FREE
DepoMed, Inc. (NASDAQ: DEPO) reported Q2 EPS of ($0.01), $0.07 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $67.7 million versus the consensus estimate of $38.03 million.
For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank's top picks in mining as copper market faces potential squeeze
- Yorkville Ives Starts Telos Corp. (TLS) at Outperform
- Hess Midstream stock drops on Chevron restructuring and lower 2027 outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
